Inhibrx Biosciences, Inc. INBX Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s other income (expense)?
- Inhibrx Biosciences, Inc. (INBX) reported other income (expense) of -$2.51M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s other income (expense) changed year-over-year?
- Inhibrx Biosciences, Inc.'s other income (expense) decreased by 513.2% year-over-year, from -$410K to -$2.51M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s other income (expense)?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s other income (expense) has grown at a -50.5% compound annual growth rate (CAGR), from -$20.5M to -$5.03M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.